Source: Annual Congress 2007 - Primary care management of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Calverley, R. Stockley, T. Seemungal, G. Hagan, J. Wedzicha (Liverpool, Birmingham, London, United Kingdom; Mt Hope, Trinidad And Tobago). Adverse events and mortality in the INSPIRE study (investigating new standards for prophylaxis in reduction of exacerbations). Eur Respir J 2007; 30: Suppl. 51, 847

Member's Comments

No comment yet.

Related content which might interest you: Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Patterns of risk of death and asthma-related adverse outcomes in adult asthma patients receiving long-acting β2-agonist (LABA) therapy: results from the UK general practice research database (GPRD) Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care Year: 2009 QVA149 does not increase the risk of cardio- and cerebro-vascular events, pneumonia and exacerbation events compared with placebo: A network meta-analysis across multiple safety databases Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Rates of major cardiovascular events in severe asthma: US real-world and clinical trial populations Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Risk of non-lower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT trial Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010 Adverse events and cardiovasular effects of vilanterol in paediatric asthma: a systematic review Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019 Premature discontinuation of patients: a potential bias in COPD clinical trials Source: Eur Respir J 2007; 30: 898-906 Year: 2007 Adherence to medication, mortality and severe exacerbations in the TORCH study Source: Annual Congress 2008 - COPD Year: 2008 Long-acting bronchodilators (LABDs) and major adverse cardiac events (MACE) in patients with COPD: A pooled analysis of 12 randomised trials Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Incidence and risk factors of frequent asthma exacerbations in a multinational, multidatabase cohort study Source: International Congress 2019 – Epidemiology of airway diseases in primary care Year: 2019 Incidence and risk factors of pediatric asthma exacerbations in a multinational, multidatabase cohort study Source: International Congress 2018 – New developments in paediatric asthma Year: 2018 Persistence to COPD therapies and impact on exacerbations: a French claims data study Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Predictors of long-term mortality after hospitalization for COPD; A Scandinavian multicentre study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Late Breaking Abstract - Cardiovascular adverse events of drugs targeting IL-5 in severe asthma: a pharmacovigilance study Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020 Pharmacological management and risk of mortality after first COPD hospitalization (HERA) Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Effect of salmeterol/fluticasone propionate versus tiotropium bromide on withdrawal rate, health status, lung function and mortality: INSPIRE (investigating new standards for prophylaxis in reduction of exacerbations) study Source: Eur Respir J 2007; 30: Suppl. 51, 34s Year: 2007 The effects of antibiotic therapy at the pre-hospital stage on the in-hospital mortality in adults with community-acquired pneumonia in Russia: observational study results. Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Incidence and risk factors for acute exacerbations of asthma during pregnancy: A prospective observational study of 500 pregnancies Source: Annual Congress 2013 –Highlights in epidemiology of respiratory disease Year: 2013 Metrics of salbutamol use as predictors of future adverse outcomes in asthma Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 Reduction in fatal events with extrafine inhaled corticosteroid (ICS)-containing medications: results of stratified safety pooled analysis of the TRILOGY, TRINITY and TRIBUTE studies. Source: International Congress 2018 – Clinical trials in COPD: new results Year: 2018